Clinical Trial Update: Impact of Dexmedetomidine on Acute Kidney Injury Following Living Donor Liver Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the impact of dexmedetomidine on acute kidney injury after living donor liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Liver Diseases

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Asan Medical Center | Conditions: Acute Kidney Injury, Liver Diseases | Phase 4 | Status: UNKNOWN